KALA - KALA BIO, Inc.
3.4499
0.000 -0.003%
Share volume: 184,273
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$3.45
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-09-2023 | 08-04-2023 | 05-14-2024 | 08-06-2024 | 11-12-2024 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | |||
| Operating expenses | 10.066 M | 9.240 M | 11.773 M | 9.634 M | 9.568 M | |
| Selling general and admin | 6.030 M | 4.962 M | 5.422 M | 4.317 M | 4.400 M | |
| Research and development | 4.036 M | 4.278 M | 6.351 M | 5.317 M | 5.168 M | |
| Total expenses | 9.836 M | 9.240 M | 11.931 M | 9.605 M | 9.988 M | |
| -6.06% | 29.12% | -19.50% | 3.99% | |||
| Operating income | -9.836 M | -9.240 M | -11.931 M | -9.605 M | -9.988 M | |
| Ebit | -9.836 M | -9.240 M | -10.856 M | -8.625 M | -8.042 M | |
| Pretax income | -14.455 M | -10.413 M | -11.807 M | -9.579 M | -8.950 M | |
| -27.96% | 13.39% | -18.87% | -6.57% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -14.455 M | -10.413 M | 0.000 | 0.000 | 0.000 | |
| 27.96% | 100.00% | |||||
| Net income | -14.455 M | -10.413 M | -11.807 M | -9.579 M | -8.950 M | |
| 27.96% | -13.39% | 18.87% | 6.57% |
